The association between systemic glucocorticoid therapy and the risk of infection in patients with rheumatoid arthritis: systematic review and meta-analyses

Whereas observational studies suggested an increased risk of infection with GC therapy, RCTs suggested no increased risk. Inconsistent reporting of safety outcomes in the RCTs, as well as marked heterogeneity, probable residual confounding, and publication bias in the observational studies, limits the opportunity for a definitive conclusion. Clinicians should remain vigilant for infection in patients with RA treated with GC therapy.

 

 

Authors: Dixon, W. G.; Suissa, S.; Hudson, M. 

Title: The association between systemic glucocorticoid therapy and the risk of infection in patients with rheumatoid arthritis: systematic review and meta-analyses

Year: 2011

Journal: Arthritis Res Ther

Volume: 13

Issue: 4

Pages: R139

Pubmed Link: Click here.

Previous Article

Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published...

Next Article

EULAR evidence-based and consensus-based recommendations on the management of medium...